Panandiker Kaya Kamlesh Pai - 10 Nov 2025 Form 3 Insider Report for LB PHARMACEUTICALS INC

Role
Chief Commercial Officer
Signature
/s/ Marc Panoff, Attorney-in-Fact
Issuer symbol
LBRX on Nasdaq
Transactions as of
10 Nov 2025
Net transactions value
$0
Form type
3
Filing time
18 Nov 2025, 18:57:57 UTC
Next filing
11 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pai Panandiker Kaya Kamlesh Chief Commercial Officer C/O LB PHARMACEUTICALS INC, ONE PENNSYLVANIA PLAZA, SUITE 1025, NEW YORK /s/ Marc Panoff, Attorney-in-Fact 18 Nov 2025 0002095250

No securities are beneficially owned.